Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
inflammation and how natural inhibitors called tanshinones can ‘switch off’ harmful inflammatory pathways. These compounds are already being tested in clinical trials, but there’s much more to uncover about how
-
. For more information about how Knowledge Transfer Partnerships can accelerate your career, visit: https://iuk-ktp.org.uk/ You must evidence the following essential criteria in you application: A PhD (or MSc
-
optimization, cell component manufacturing, and the testing of solid-state battery performance. This role involves intense collaboration with international partners and the dissemination of results within the EU
-
nanoplastics and degradation products and the investigation of their toxicity in in vitro cellular models, within the scope of the European project BMRex -Biocatalytic membranes for micro/nano plastic
-
top academia, industry and research centres; the opportunity to contribute to the Φ-lab strategy and activities. Candidates interested are encouraged to visit the ESA website: http://www.esa.int Field(s
-
recruitment process, can be found at https://accedtp.ac.uk/, in the ‘prospective applicants’ tab. Project overview Importance. Tropical forests cover ~15% of the world’s terrestrial surface. They play a crucial
-
” (COMPETE2030), taking place at the RISE-Health, University of Beira Interior (UBI) (http://www.cics.ubi.pt/ ), under the following conditions: Scientific Area: Chemistry, Biochemistry, Biotechnology, Biomedical
-
to degradation of the interface between the matrix and the filler/reinforcement, these studies will be complemented by SEM analyses of these interfaces. Where to apply Website https://emploi.cnrs.fr/Candidat/Offre
-
degradation or a reduction in component life. 6. Collaboration with BDR Thermea – design and testing of a prototype heat pump using the new reactive fluid and an inert fluid. In collaboration with industrial
-
tightly controlled and active TPL-2 is rapidly degraded to limit the activation of downstream pathways. We previously demonstrated that TPL-2 is a nuclear-cytoplasmic shuttling protein that undergoes